{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:05:13Z","timestamp":1771646713399,"version":"3.50.1"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,15]]},"DOI":"10.2169\/internalmedicine.6212-25","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:08:40Z","timestamp":1760566120000},"page":"596-600","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged Diagnostic Latency and Long-term Surveillance in Anti-Ri Antibody-positive Opsoclonus-myoclonus Syndrome with Carcinoma of Unknown Primary"],"prefix":"10.2169","volume":"65","author":[{"given":"Momoyo","family":"Ibukuro","sequence":"first","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kida","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sarukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Simard C, Vogrig A, Joubert B, et al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflamm 7: e699, 2020.","DOI":"10.1212\/NXI.0000000000000699"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Marsili L, Marcucci S, LaPorta J, Chirra M, Espay AJ, Colosimo C. Paraneoplastic neurological syndromes of the central nervous system: pathophysiology, diagnosis, and treatment. Biomedicines 11: 1406, 2023.","DOI":"10.3390\/biomedicines11051406"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Oh SY, Kim JS, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol 266: 1541-1548, 2019.","DOI":"10.1007\/s00415-018-9138-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Armangu\u00e9 T, Sabater L, Torres-Vega E, et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 73: 417-424, 2016.","DOI":"10.1001\/jamaneurol.2015.4607"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bataller L, Graus F, Saiz A, Vilchez JJ; Spanish Opsoclonus-Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. 124: 437-443, 2001.","DOI":"10.1093\/brain\/124.2.437"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med 371: 757-765, 2014.","DOI":"10.1056\/NEJMra1303917"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bardak\u00e7i M, Algin E, D\u00fc\u011fero\u011flu B, Bal \u00d6, K\u00f6\u015f FT, Uncu D. Management and prognosis of patients with cancer of unknown primary: 20 years of experience. Turk J Med Sci 53: 1722-1731, 2023.","DOI":"10.55730\/1300-0144.5741"},{"key":"8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1186\/s12885-023-11563-1","volume":"23","author":"M Ren","year":"2023","unstructured":"8. Ren M, Cai X, Jia L, et al. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China. BMC Cancer 23: 1175, 2023.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 8: e1014, 2021.","DOI":"10.1212\/NXI.0000000000001014"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kim H, Lim Y, Kim KK. Anti-Ri-antibody-associated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI. J Clin Neurol 5: 151-152, 2009.","DOI":"10.3988\/jcn.2009.5.3.151"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Musunuru K, Kesari S. Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma. J Neurooncol 90: 213-216, 2008.","DOI":"10.1007\/s11060-008-9650-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mondrag\u00f3n JD, Jim\u00e9nez-Zaraz\u00faa O, V\u00e9lez-Ram\u00edrez LN, et al. Paraneoplastic opsoclonus-myoclonus syndrome secondary to melanoma metastasis form occult primary cancer. Case Rep Neurol 11: 66-79, 2019.","DOI":"10.1159\/000497034"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Akhave N, Zhang J, Bayley E, et al. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment. Lung Cancer 172: 19-28, 2022.","DOI":"10.1016\/j.lungcan.2022.08.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gubin MM, Vesely MD. Cancer immunoediting in the era of immuno-oncology. Clin Cancer Res 28: 3917-3928, 2022.","DOI":"10.1158\/1078-0432.CCR-21-1804"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Freydl E, Tinchon A, Blauensteiner K, Oberndorfer S. Anti-Ri paraneoplastic neurological syndrome presenting with bilateral cranial nerve VI palsy and jaw dystonia - a distinctive syndrome within the anti-Ri spectrum?: case report and literature review. Wien Med Wochenschr 174: 16-21, 2024.","DOI":"10.1007\/s10354-023-01006-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ross JS, Sokol ES, Moch H, et al. Comprehensive genomic profiling of carcinoma of unknown primary origin: retrospective molecular classification considering the CUPISCO study design. Oncologist 26: e394-e402, 2021.","DOI":"10.1002\/onco.13597"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_6212-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:43:12Z","timestamp":1771645392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_6212-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6212-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"article-number":"6212-25"}}